Table 3 Sexual behaviors in the past 6 months and their associations with KSHV seropositivity among MSM
Variables | Seropositive (%) | ORs (95%CI) | aORs (95%CI)a |
|---|---|---|---|
Forms of sex | |||
Oral sex | 21/47 (44.7) | 1.00 | 1.00 |
Anal sex | 16/32 (50.0) | 1.24 (0.50–3.05) | 1.77 (0.69–4.59) |
Both | 163/393 (41.5) | 0.88 (0.48–1.61) | 1.00 (0.53–1.90) |
Role during anal sex | |||
Insertive | 61/154 (39.6) | 1.00 | 1.00 |
Receptive | 54/116 (46.6) | 1.33 (0.82–2.16) | 1.19 (0.71–1.98) |
Both | 85/202 (42.1) | 1.11 (0.72–1.70) | 1.01 (0.65–1.59) |
Male sex partners | |||
1 | 56/153 (36.6) | 1.00 | 1.00 |
≥ 2 | 144/319 (45.1) | 1.43 (0.96–2.12) | 1.56 (1.03–2.38)* |
Condom use for anal sex with man | |||
Inconsistently | 76/192 (39.6) | 1.00 | 1.00 |
Consistently | 124/280 (44.3) | 1.21 (0.84–1.76) | 1.17 (0.80–1.72) |
Ever had sex with woman | |||
No | 205/450 (45.6) | 1.00 | 1.00 |
Yes | 23/70 (32.9) | 0.58 (0.34–1.00)* | 0.62 (0.36–1.07) |
Used saliva as a lubricant during anal sex | |||
No | 129/272 (47.4) | 1.00 | 1.00 |
Yes | 99/248 (39.9) | 0.74 (0.52–1.04) | 0.77 (0.53–1.10) |
Ever used recreational drug | |||
No | 131/301 (43.5) | 1.00 | 1.00 |
Yes | 97/219 (44.3) | 1.03 (0.73–1.47) | 1.09 (0.75–1.56) |